Hanson & Doremus Investment Management - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 78 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
Hanson & Doremus Investment Management ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$9
-18.2%
3200.0%0.00%0.0%
Q2 2023$11
+37.5%
3200.0%0.00%0.0%
Q1 2023$8
-38.5%
3200.0%0.00%
-33.3%
Q4 2022$13
-99.9%
3200.0%0.00%0.0%
Q3 2022$11,0000.0%3200.0%0.00%0.0%
Q2 2022$11,000
-26.7%
3200.0%0.00%0.0%
Q1 2022$15,000
-28.6%
3200.0%0.00%
-25.0%
Q4 2021$21,000
+5.0%
3200.0%0.00%
-20.0%
Q3 2021$20,000
+42.9%
3200.0%0.01%
+25.0%
Q2 2021$14,000
-33.3%
3200.0%0.00%
-20.0%
Q1 2021$21,000
-16.0%
3200.0%0.01%
-16.7%
Q4 2020$25,000
+78.6%
3200.0%0.01%
+50.0%
Q3 2020$14,0000.0%3200.0%0.00%0.0%
Q2 2020$14,000
+55.6%
3200.0%0.00%
+33.3%
Q1 2020$9,000
-70.0%
320
-31.9%
0.00%
-66.7%
Q4 2019$30,000
+130.8%
4700.0%0.01%
+125.0%
Q3 2019$13,000
+8.3%
4700.0%0.00%0.0%
Q2 2019$12,000
+33.3%
4700.0%0.00%
+33.3%
Q1 2019$9,000
+50.0%
4700.0%0.00%
+50.0%
Q4 2018$6,000
-33.3%
4700.0%0.00%
-33.3%
Q3 2018$9,000
+50.0%
4700.0%0.00%
+50.0%
Q2 2018$6,000
+100.0%
4700.0%0.00%
+100.0%
Q1 2018$3,000
+50.0%
4700.0%0.00%0.0%
Q4 2017$2,0000.0%4700.0%0.00%0.0%
Q3 2017$2,000
+100.0%
4700.0%0.00%
Q2 2017$1,0000.0%4700.0%0.00%
Q1 2017$1,000
-99.9%
4700.0%0.00%
Q4 2016$729,000
+24200.0%
4700.0%0.00%
-100.0%
Q3 2016$3,0004700.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2017
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,303$54,386,00028.54%
JOHNSON & JOHNSON 3,260,869$216,196,00024.61%
ACT CAPITAL MANAGEMENT, LLC 210,500$13,956,00010.09%
Aquilo Capital Management, LLC 700,426$46,438,0005.27%
WEALTH EFFECTS LLC 145,960$9,677,0004.02%
Evolutionary Tree Capital Management, LLC 115,580$7,663,0003.68%
ACUTA CAPITAL PARTNERS, LLC 105,500$6,995,0002.94%
Privium Fund Management B.V. 204,393$13,766,0002.73%
L1 Capital Pty Ltd 292,735$19,408,0002.24%
Avidity Partners Management LP 875,000$58,013,0001.23%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders